The Steering Committee
Dennis C. Turk, PhD
eHealthcare Leadership Awards 2007 Winner

W3 Awards Silver Winner 2007

WWW Merit Health Awards 2007
PPS Educational Links
You need to upgrade your Flash Player

Member Login
Username:

Password:
Need to register?
Forgot Password?


Calendar of Events
Grantors
Gold
AR Scientific, Inc.
Endo Pharmaceuticals, Inc
Silver
Bronze
Poll
Which assessment tool do you use most often in your clinical practice?






You need to upgrade your Flash Player to view this content.

What's New?

Pain Management Today
Read the latest issue of Pain Management Today and receive .75 AMA PRA Category 1 Credits.   The first article discusses opioid rotation, conversion, and titration and how to handle the need for escalating doses when tolerance or disease progression cause efficacy to wane.  The second article focuses on the challenges faced by clinicians in recognizing which patients are most at risk for abusing opioids.
Webcast on Opioid Analgesia
Listen to a webcast from the successful National Initiative on Pain Control DINNER DIALOGUES® series entitled: Advances in Opioid Analgesia: Evolving Strategies to Chronic Pain and receive 1.5 AMA PRA Category 1 Credits.
On-Demand Activities
Three interactive, case-based activities, originally posted on LegDisorders.org, are now featured here! Participate today and earn instant AMA PRA Category 1 Credit.
Downloadable Slides on Rotation, Titration, and Conversion
Visit the Dynamic Slide Library to access downloadable slides on how to optimize opioid therapy through rotation, titration, and conversion. An opioid conversion calculator to determine equianalgesic values is included. Create your own presentations, download slides onto your computer, or share them with a colleague!

Slides of the Month
 

  slide Opioid Titration
Titration of the opioid dose is often necessary at the start of a new therapy and repe...
View all Slides

  slide Opioid Titration Protocol
The titration of an opioid analgesic should be made, if needed, 3 days after the initi...
View all Slides

  slide Opioid Conversion
Long-acting opioids have greater utility than short-acting opioids in treating chronic...
View all Slides

  slide Opioid Rotation
Opioid rotation refers to the switching from one opioid to another when the degree of ...
View all Slides

  slide Mu-agonist Dose Chart*
The clinical benefits of opioid rotation have focused attention on efficacy difference...
View all Slides

  slide Opioid Conversion Calculator
An example of an opioid conversion: patient previously using MS Contin is switched to ...
View all Slides

  slide Analgesic Equivalence Calculation
The analgesic equivalence conversion should take into account individual patient chara...
View all Slides

  slide Rotating From Morphine to Oxymorphone ER
This is an example of calculating the equianalgesic dose for rotating a patient from m...
View all Slides

  slide Rotating From Morphine to Transdermal Fentanyl
This is an example of calculating the equianalgesic dose for rotating a patient from m...
View all Slides

  slide Fentanyl Buccal Tablet for BTP in Opioid-Tolerant Patients
This study, supported by Cephalon Inc., evaluated the analgesic efficacy and tolerabil...
View all Slides

  slide Fentanyl Buccal Tablet for BTP Results: Change in Mean PID Score
Of 102 patients in the open-label titration period, 79 entered the double-blind phase....
View all Slides

  slide Fentanyl Buccal Tablet for BTP: Conclusions
In these opioid-tolerant patients with chronic neuropathic pain who were titrated to a...
View all Slides


In the News
Medicinal Marijuana Effective For Neuropathic Pain In HIV
Aug 07, 2008 -- In a double-blind, placebo-controlled clinical trial to assess the impact of smoked medical cannabis, or marijuana, on the neuropathic pain associated with HIV, researchers at the University of California, San Diego School of Medicine found that reported pain relief was greater with cannabis than with a placebo.
Molecule CX717 Has Positive Effects In Opiate-Induced Respiratory Depression In A Phase IIa Clinical Study
Aug 07, 2008 -- Cortex Pharmaceuticals, Inc. (AMEX: COR - News) reported that top-line data from its first Phase IIa study in opiate-induced respiratory depression (RD) demonstrated that a single oral dose of 2100mg of AMPAKINE® CX717 achieved statistical significance over placebo on the primary endpoint measure.
Copyright 2007 Medical News Today